ArticleInternational journal of chronic obstructive pulmonary disease

Efficacy and safety of a novel, nebulized glycopyrrolate for the treatment of COPD: effect of baseline disease severity and age; pooled analysis of GOLDEN 3 and GOLDEN 4.

Jill Ohar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.